Disparities in Respiratory Syncytial Virus Vaccine Uptake in the Medicare Fee‐for‐Service Population During 2023–2024 Season
Vaccination to prevent RSV disease began during the 2023-2024 season where less than a quarter of the Medicare FFS population was vaccinated. Disparities in uptake were observed by race and ethnicity, socioeconomic status, geography, comorbidity status, and by age group. These results highlight the need for more targeted public health efforts to improve vaccination among those at high risk for severe RSV disease.
Authors
- P. Kardel
- Heidi G. De Souza (ORCID: https://orcid.org/0000-0002-7015-174X)
- Adrianna Murphy (ORCID: https://orcid.org/0000-0003-4065-6744)
- Erica Chilson (ORCID: https://orcid.org/0000-0002-4417-3398)
- Reiko Sato
- Caitlin Sheetz
- Zihao Liu
- Robyn Moucka
Institutions
- Pfizer (United States) (US)
- Health Strat (Kenya) (KE)
Publication Details
- Journal
- Journal of the American Geriatrics Society
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1111/jgs.19610
- Citations
- 4
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 5.42
Funders
- Pfizer